How the business world celebrated Christmas!
The government will investigate every Indian name appearing in an unprecedented leak of financial records, known as the 'Pandora Papers', which alleged that many world leaders have secret offshore stores of wealth.
Which entrepreneur would willingly part with her or his hard-earned money for grasping, self-serving politicians? asks Debashis Basu.
It's truly women on top as all four Indian corporate leaders featuring in Forbes' list of Asia Pacific's most generous business personalities this year are women.
Savitri Jindal has retained the tag of being the richest woman in India with a networth of $5.2 billion
Proxy advisory firms say the praise on Twitter was uncalled for.
Reliance Industries Chairman Mukesh Ambani retains the title of India's richest man with personal assets of $18.9 billion.
Learn how the founder of India's first and largest biotechnology company dealt with failure and achieved success.
The Bengaluru-based firm has entered into a definitive agreement with Mylan for an exclusive strategic collaboration for the global development and commercialisation of generic versions of its three insulin analog products, Biocon Ltd said in a statement.
Industry must take strong collective action to protect the reputation it enjoys in global markets, says Kiran Mazumdar Shaw.
Taking a break from their hectic schedule and boardroom meetings, nine CEOs would display their singing prowess at a charity dinner event in Bengaluru to raise funds for children on July 16.
ICICI Bank CEO and MD Chanda Kochchar, Biocon founder Kiran Mazumdar-Shaw and film producer Ekta Kapoor are among the nine Indian women named in Forbes magazine's inaugural 'Asia Power Businesswomen list'.
Industry leaders have urged the government to carry forward the reforms process.
Other corporate leaders, including Biocon chief Kiran Mazumdar Shaw, UB Group Chairman Vijay Mallya and Mahindra Group vice-chairman Anand Mahindra, have also expressed concerns over the current state of economy in the country.
In this second part - of 'Glass-ceiling in India' - we bring you India's successful entrepreneurs. These women are stereotype-busters in their own right.
The company has launched the product in 10ml and 3ml vials, Biocon said.
Nine Indians, including Prime Minister Manmohan Singh, cricket legend Sachin Tendulkar and economist Amartya Sen have been named in Time magazine's annual list of 100 most influential people.
Fourth edition of TiE Chennai's TiECON, Chennai 2011 will be held on November 24.
After registering encouraging data from oral insulin trials, Biocon is looking to partner on this with global pharma firms.
India's biotechnology industry is pushing the government for fiscal incentives, import duty exemption and correction of policy that gives MNCs higher drug prices than "desi" producers, ahead of the Union budget.
Three Indians PepsiCo chief Indra Nooyi, ICICI Bank's CEO Chanda Kocchar and Kiran Mazumdar Shaw of Biocon -- have been listed in 'The World's 100 Most Powerful Women' list by Forbes magazine.
Every year, BioSingapore receives nominations from biotechnology industry associations, industry peers, academics and institutions across Asia-Pacific for the most outstanding companies or individuals in various categories. The nominees are judged by a panel of distinguished leaders in the field.
Bt brinjal is a genetically-modified vegetable which is infused with Cry1Ac gene from a bacterium Bacillus thuringiensis to make the plant resistant to the fruit and shoot borers and certain pests.
Biocon was scouting for more strategic alliances and exploring opportunities for outlicensing its biotech drugs under development, as it pitches for a slot among the top three bio-pharmaceutical players across the globe, said Kiran Mazumdar-Shaw, chairman and managing director.
"My view on taxation levels in India is that it is at a reasonable level and I think what is more important is how the government uses taxpayers' money," said Kiran Mazumdar-Shaw, the Chairman and Managing Director of Biocon, India's largest biotech company by revenue, said.
Biotechnology major Biocon on Tuesday said it aims to achieve revenues of $1 billion in the next three years.
The Biocon chairman said there is a regulatory path for GM crops which aims to establish safety and efficacy over an accepted period and it has been diligently followed by Bt brinjal on the basis of which the Genetic Engineering Approval Committee has given its positive verdict.
Chaitanya Sagar Bethu (ISB Class of 2010) shares his experience of spending the day with Narayana Murthy, Infosys chief mentor.
Union Finance Minister P Chidambaram regretted that there has been stiff resistance from certain quarters over the reservation bill, which would ensure 33 per cent seats for women in Parliament and legislatures. Chidambaram said this while releasing the book Karmic Divas -- stories of eight powerful and wealthy women written by Prerna Kaul Misra and printed by Vitasta publications.
Ajay Lakhotia, an ISB student, shares his experience of spending the day with former managing director and CEO of ICICI Bank KV Kamath and the management lessons that this young MBA grad has learnt from the banking veteran.
Clinical trials, agri-biotech and bio-fuels are becoming opportunities. There are a lot of growth drivers and trigger points which, she said, will deliver in the next five years.
As Shah Rukh Khan and Yusuf Arakkal and Rana Dasgupta and Kiran Mazumdar Shaw stand for the best of us, there is too much in daily life that showcases us at our apathetic, or misguided, worst, says Sheba Thayil in this Independence Day column.
"We will continue to hire people as our growing business demands manpower," CMD Kiran Mazumdar Shaw told reporters while announcing the company's half-yearly results.
Researchers and scientists in India would have to be innovative if the country wished to unleash its vast intellectual potential, chairman and managing director of Biocon Ltd Kiran Mazumdar Shaw said on Saturday.
In an interview with Nandita Datta she talks about biotechnology becoming the new buzzword and what it takes to build a successful career.
The Indian biotech sector continues to face an acute shortage of specialists. But now there is a ray of hope, interestingly from a dark story being narrated in the pharma and biotech sectors in the United States and Europe. The sector is seeing downsizing there. This has made scientists of Indian origin explore opportunities in India. "The shortage and the noticeable gap is in terms of discovery-led drug development," said Kiran Mazumdar Shaw, CMD, Biocon
As many as six women, including O P Jindal group chairperson Savitri Jindal and Biocon's Kiran Mazumdar Shaw, have made it to the Forbes' list of 100 richest Indians this year.
Biotechnology major Biocon has got the Drug and Controller General of India approval for marketing its BIOMAb EGFR in the Indian market. This is a proprietary product of Biocon, which will be used in treating head and neck cancers.
Amateur filmmaker Anubhav Srivastava on how his unique film project changed his life.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances